Trial intelligence / Profile preview

Plasma-Lyte 148 versus normal saline in deceased-donor kidney transplantation

ACTRN12612000023853Phase 4Completed

Sponsor
Austin Hospital
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of plasma-lyte and Normal Saline-Benha University in kidney failure (2 arms), sponsored by Austin Hospital. Primary endpoints: Standard base deficit, Serum potassium and 1 more. Started Nov 2012; status: completed.

02

Drugs

plasma-lyteNormal Saline-Benha University
03

Conditions

kidney failure

Beyond the preview

Go deeper on ACTRN12612000023853.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612000023853.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call